LifeStance Health Group (NASDAQ:LFST) Now Covered by Analysts at Canaccord Genuity Group

Canaccord Genuity Group began coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research note published on Thursday morning, Marketbeat reports. The firm issued a buy rating and a $8.00 price objective on the stock.

Other research analysts also recently issued research reports about the company. The Goldman Sachs Group upgraded LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price objective on the stock in a report on Monday, December 16th. William Blair reaffirmed an “outperform” rating on shares of LifeStance Health Group in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $8.50.

LifeStance Health Group Price Performance

Shares of NASDAQ LFST opened at $6.74 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.32 and a quick ratio of 1.32. The company has a market cap of $2.59 billion, a price-to-earnings ratio of -25.92 and a beta of 1.27. The stock’s 50-day moving average is $7.49 and its two-hundred day moving average is $7.34. LifeStance Health Group has a 1-year low of $4.64 and a 1-year high of $8.61.

Insider Activity at LifeStance Health Group

In other news, insider Lisa K. Miller sold 18,845 shares of the firm’s stock in a transaction on Monday, March 17th. The shares were sold at an average price of $6.90, for a total value of $130,030.50. Following the completion of the sale, the insider now owns 339,810 shares in the company, valued at approximately $2,344,689. This trade represents a 5.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 6.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Wellington Management Group LLP increased its position in LifeStance Health Group by 9.2% during the 4th quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock worth $38,886,000 after purchasing an additional 445,796 shares during the period. Forum Financial Management LP acquired a new position in LifeStance Health Group during the fourth quarter worth $110,000. Neo Ivy Capital Management raised its position in LifeStance Health Group by 26,132.3% in the fourth quarter. Neo Ivy Capital Management now owns 182,052 shares of the company’s stock worth $1,341,000 after acquiring an additional 181,358 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in LifeStance Health Group by 16.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 604,321 shares of the company’s stock valued at $4,454,000 after acquiring an additional 87,502 shares during the period. Finally, Vident Advisory LLC purchased a new stake in shares of LifeStance Health Group during the 4th quarter worth $156,000. 85.50% of the stock is owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.